Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 13

TABLE OF CONTENTS 4 PREMIUM INSIGHTS.................................................................................................................32 • 4.1 GLOBAL HUMAN INSULIN MARKET (2015–2020)..................................................................... .....................................32 • 4.2 GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE (2015)...............................................................................33 • 4.3 GLOBAL HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE (2015-2020)..................................................34 • 4.4 GLOBAL HUMAN INSULIN DRUGS MARKET, BY BRAND (2015 VS. 2020).....................................................................34 • 4.5 GLOBAL HUMAN INSULIN PRODUCTS MARKET SIZE, BY COUNTRY (2015-2020).......................................................35 5 MARKET OVERVIEW..................................................................................................................36 • 5.1 INTRODUCTION...............................................................................................................................................................37 • 5.2 MARKET SEGMENTATION................................................................................................................................................37 • 5.3 MARKET EVOLUTION.......................................................................................................................................................38 • 5.4 MARKET DYNAMICS........................................................................................................................................................39 • 5.4.1 KEY MARKET DRIVERS..................................................................................................................................40 • 5.4.1.1 GROWTH IN THE NUMBER OF DIABETIC PATIENTS................................................................40 • 5.4.1.2 RISING MARKET DEMAND FOR HUMAN INSULIN ANALOGS.................................................41 • 5.4.1.3 TECHNOLOGICAL ADVANCEMENTS IN HUMAN INSULIN DELIVERY DEVICES......................42 • 5.4.1.4 FAVORABLE MEDICAL REIMBURSEMENT SCENARIO IN DEVELOPED COUNTRIES...............43 • 5.4.2 • • KEY MARKET RESTRAINTS............................................................................................................................43 5.4.2.1 5.4.3 STRINGENT REGULATORY REQUIREMENTS FOR PRODUCT APPROVAL................................43 KEY MARKET OPPORTUNITIES.....................................................................................................................44 • 5.4.3.1 EXPANSION OF HEALTHCARE INFRASTRUCTURE ACROSS EMERGING MARKETS...............44 • 5.4.3.2 EXPECTED PATENT EXPIRY OF KEY HUMAN INSULIN DRUGS...............................................45 • • 5.4.4 KEY MARKET CHALLENGE............................................................................................................................45 5.4.4.1 [email protected] HIGH PRODUCT MANUFACTURING COSTS............................................................................45 www.marketsandmarkets.com 13